Poole Sandra
SEC CIK 1619622 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | Dir | 34.0K | — | — | 5 | 2022-05-11 | 2026-05-19 |
Most active insiders at TVTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dube Eric M | CEO, Dir | — | $41.35M |
| 2 | Heerma Peter | EVP, Chief COMMERCIAL Off | — | $18.97M |
| 3 | ROTE WILLIAM E. | Chief Research Off | — | $16.43M |
| 4 | REED ELIZABETH E | CLO, GC | — | $7.02M |
| 5 | Inrig Jula | EVP, CMO, Head of R, D | — | $5.16M |
| 6 | Cline Christopher R. | CFO | — | $4.64M |
| 7 | Calvin Sandra | SVP, CAO | — | $4.19M |
| 8 | Baynes Roy D. | Dir | — | $2.55M |
| 9 | Meckler Jeffrey A | Dir | — | $1.71M |
| 10 | Coughlin Timothy | Dir | — | $1.27M |
| 12 | Poole Sandra | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-21 17:00 | 2026-05-19 | TVTX | Travere Therapeutics, Inc. | Poole Sandra | Dir | A - Grant | $0.00 | +4,000 | 34.0K | +13% | $0 |
| D | 2025-05-16 | 2025-05-15 | TVTX | Travere Therapeutics, Inc. | Poole Sandra | Dir | A - Grant | $0.00 | +6,500 | 30.0K | +28% | $0 |
| D | 2024-05-10 | 2024-05-08 | TVTX | Travere Therapeutics, Inc. | Poole Sandra | Dir | A - Grant | $0.00 | +6,500 | 23.5K | +38% | $0 |
| D | 2023-05-19 | 2023-05-17 | TVTX | Travere Therapeutics, Inc. | Poole Sandra | Dir | A - Grant | $0.00 | +4,500 | 17.0K | +36% | $0 |
| D | 2022-05-12 | 2022-05-11 | TVTX | Travere Therapeutics, Inc. | Poole Sandra | Dir | A - Grant | $0.00 | +3,000 | 12.5K | +32% | $0 |
Purchase Sale Sale after option exercise All abbreviations